Peer Reviewed
Perspectives

Risk scores to predict stroke in atrial fibrillation

John Amerena
Abstract
Preventing stroke in patients with nonvalvular atrial fibrillation should be the major therapeutic consideration, with the CHAD2 score being the most validated risk calculator for stroke in these patients.
Key Points
  • Stroke prevention in patients with nonvalvular atrial fibrillation (AF) should be the major therapeutic consideration.
  • The CHADS2 score is the most widely used and validated risk calculator for stroke in patients with nonvalvular AF.
  • Bleeding risk also needs to be taken into account when considering anticoagulation in patients with nonvalvular AF.
  • Well-controlled warfarin treatment is effective in stroke prevention in patients with nonvalvular AF but dabigatran is easier to use, safer and more effective.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?